Provided by Tiger Trade Technology Pte. Ltd.

MediWound

12.94
-0.2700-2.04%
Volume:49.88K
Turnover:647.95K
Market Cap:167.06M
PE:-8.28
High:13.27
Open:13.19
Low:12.86
Close:13.21
52wk High:20.30
52wk Low:12.86
Shares:12.91M
Float Shares:9.06M
Volume Ratio:1.40
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5630
EPS(LYR):-2.0990
ROE:-72.37%
ROA:-28.59%
PB:4.69
PE(LYR):-6.16

Loading ...

Company Profile

Company Name:
MediWound
Exchange:
NASDAQ
Establishment Date:
2000
Employees:
121
Office Location:
42 Hayarkon Street,Yavne,Israel
Zip Code:
8122745
Fax:
- -
Introduction:
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Directors

Name
Position
Nachum Shamir
Chairman of the Board and Director
David Fox
Director
Shmuel Rubinstein
Director
Stephen T. Wills
Director
Vickie R. Driver
Director

Shareholders

Name
Position
Ofer Gonen
Chief Executive Officer
Shmulik Hess
Chief Commercial Officer and Chief Operating Officer
Hani Luxenburg
Chief Financial Officer
Ety Klinger
Chief Medical Officer
Yaron Meyer
Corporate Secretary and Executive Vice President and General Counsel